A comparative study on condition of hypertensive and non-hypertensive patients with dental implant success and survival: 15 years follow ups
DOI:
https://doi.org/10.18203/2349-2902.isj20251162Keywords:
Dental implant, GBR, Sinus elevation, Uncontrolled hypertensive patients, Non-hypertensive, Success, SurvivalAbstract
Background: The study evaluates the success and survival of dental implants in hypertensive and non-hypertensive patients over a 15-year follow-up period. Hypertension may affect osseointegration and implant longevity, necessitating careful assessment of its impact on implant success.
Methods: This comparative study was conducted at Banasree Dental and Implant Center and German Dental and Implant Center, Dhaka, Bangladesh. A total of 109 patients were initially selected, but 19 were excluded due to loss to follow-up. Finally, 90 patients (67 females, 23 males, 45 in each group) were included, receiving a total of 257 implants (135 implants in maxilla and 122 implants in mandible), including guided bone regeneration (GBR) and sinus elevation. Participants aged 35 to 70 years underwent implant surgeries in 2009, with follow-ups until 2024.
Results: Marginal bone loss ranged from 0.5 mm to 2.0 mm, which is within the normal limit. All implants (100%) remained functional, with no significant difference in outcomes between hypertensive and non-hypertensive groups. This suggests that well-integrated implants can achieve long-term survival even in uncontrolled hypertensive patients.
Conclusions: With careful planning, proper blood pressure management, and close collaboration between healthcare providers, dental implants can be a durable and successful tooth replacement option for hypertensive patients. Ensuring optimal preoperative, intraoperative, and postoperative care is crucial for long-term implant stability, regardless of hypertension status.
Metrics
References
WHO Hypertension. Available at: https://www.who.int/health. Accessed on 21August 2024.
Romandini M, De Tullio I, Congedi F, Kalemaj Z, D ‘Ambrosio M, Laforí A, et al. Antibiotic prophylaxis at dental implant placement: Which is the best protocol? A systematic review and network meta‐analysis. J Clin Periodontol. 2019;46(3):382-95. DOI: https://doi.org/10.1111/jcpe.13080
El-Bikai R, Tahir MR, Tremblay J, Joffres M, Šeda O, Šedová L, et al. Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals. J Hypertens. 2015;33:727–35. DOI: https://doi.org/10.1097/HJH.0000000000000475
Wang TM, Hsu JF, Jee WS, Matthews JL. Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone Miner. 1993;20:251–64. DOI: https://doi.org/10.1016/S0169-6009(08)80006-2
Humar R, Zimmerli L, Battegay E. Angiogenesis and hypertension: An update. J Hum Hypertens. 2009;23:773–82. DOI: https://doi.org/10.1038/jhh.2009.63
Prewitt RL, Chen II, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol. 1982;243:243–51. DOI: https://doi.org/10.1152/ajpheart.1982.243.2.H243
Hutchins PM, Darnell AE. Observations of a decreased number of small arterioles in spontaneously hypertensive rats. Circ Res. 1974;34:161–5.
Sokolova IA, Manukhina EB, Blinkov SM, Koshelev VB, Pinelis VG, Rodionov IM. Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. Microvasc Res. 1985;30:1–9. DOI: https://doi.org/10.1016/0026-2862(85)90032-9
Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999;33:998–1001. DOI: https://doi.org/10.1161/01.HYP.33.4.998
Hansen-Smith FM, Morris LW, Greene AS, Lombard JH. Rapid micro vessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. Circ. Res. 1996;79:324–30. DOI: https://doi.org/10.1161/01.RES.79.2.324
Serné EH, Gans RO, Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension. 2001;38:238–42. DOI: https://doi.org/10.1161/01.HYP.38.2.238
Kang KY, Kang Y, Kim M, Kim Y, Yi H, Kim J, et al. The effects of antihypertensive drugs on bone mineral density in ovariectomized mice. J Korean Med Sci. 2013;28:1139–44. DOI: https://doi.org/10.3346/jkms.2013.28.8.1139
Ma L, Ji JL, Ji H, Yu X, Ding LJ, Liu K, Li YQ. Telmisartan alleviates rosiglitazone-induced bone loss in ovariectomized spontaneous hypertensive rats. Bone. 2010;47:5–11. DOI: https://doi.org/10.1016/j.bone.2010.03.016
Reid IR, Ames RW, Orr-Walker BJ. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: A randomized controlled trial. Am. J. Med. 2000;109:362–70. DOI: https://doi.org/10.1016/S0002-9343(00)00510-6
Ott SM, LaCroix AZ, Scholes D, Ichikawa LE, Wu K. Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons. Osteoporos Int. 2008;19:1315–22. DOI: https://doi.org/10.1007/s00198-008-0612-4
Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int. 2007;18:479–86. DOI: https://doi.org/10.1007/s00198-006-0259-y
Di Spirito F, Raimondo A, Di Palo MP, Martina S, Fordellone M, Rosa D, et al. Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review. Life. 2024;14(3):347. DOI: https://doi.org/10.3390/life14030347
Downloads
Published
How to Cite
Issue
Section
